North America Clinical Trials Market Size & Outlook

The clinical trials market in North America is expected to reach a projected revenue of US$ 60,647.7 million by 2030. A compound annual growth rate of 5.8% is expected of North America clinical trials market from 2024 to 2030.
Revenue, 2023 (US$M)
$40,959.3
Forecast, 2030 (US$M)
$60,647.7
CAGR, 2024 - 2030
5.8%
Report Coverage
North America

North America clinical trials market highlights

  • The North America clinical trials market generated a revenue of USD 40,959.3 million in 2023.
  • The market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
  • In terms of segment, phase iii was the largest revenue generating phase in 2023.
  • Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
  • Country-wise, U.S. is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 40,959.3 million
Market revenue in 2030USD 60,647.7 million
Growth rate5.8% (CAGR from 2023 to 2030)
Largest segmentPhase iii
Fastest growing segmentPhase I
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPhase I, Phase II, Phase III, Phase IV
Key market players worldwideThermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, PAREXEL, Wuxi AppTec Co Ltd, Labcorp Holdings Inc, Eli Lilly and Co, Novo Nordisk A/S ADR, Pfizer Inc, Caidya


Other key industry trends

  • In terms of revenue, North America region accounted for 50.7% of the global clinical trials market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 25,992.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trials Market Companies

Name Profile # Employees HQ Website

North America clinical trials market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trials market will help companies and investors design strategic landscapes.


Phase iii was the largest segment with a revenue share of 53.51% in 2023. Horizon Databook has segmented the North America clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. is the largest market for clinical trials as the country spends the highest healthcare per capita, and an increased number of clinical trials have been undertaken to seek FDA approval. In addition, many companies have shifted their focus to outsourcing emerging market players due to the increasing regulatory requirements and long approval timelines.

This has led to the majority of outsourcing activities in North America. High research cost further prompts companies to outsource clinical trials to other research organizations. Several companies, such as Parexel International Corporation and Charles River Laboratory, are present in North America.

The regional presence of these companies encourages the collaboration of technology and data management, allowing better data accessibility and trial monitoring, fueling the market demand. Moreover, the increasing number of product pipelines is encouraging big pharmaceutical & biopharmaceutical and medical device companies to invest in clinical trials R&D services.

Reasons to subscribe to North America clinical trials market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America clinical trials market databook

  • Our clientele includes a mix of clinical trials market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America clinical trials market , including forecasts for subscribers. This continent databook contains high-level insights into North America clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America clinical trials market size, by country, 2018-2030 (US$M)

North America Clinical Trials Market Outlook Share, 2023 & 2030 (US$M)

North America clinical trials market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more